medimpo limited

2

medimpo limited Company Information

Share MEDIMPO LIMITED
Live 
MatureSmallDeclining

Company Number

01761386

Registered Address

63 imperial way, croydon, croydon, CR0 4RR

Industry

Dispensing chemist in specialised stores

 

Telephone

02086639052

Next Accounts Due

August 2024

Group Structure

View All

Directors

Rajendra Patel31 Years

Vandna Patel31 Years

View All

Shareholders

medimpo holdings limited 100%

medimpo limited Estimated Valuation

£788.3k

Pomanda estimates the enterprise value of MEDIMPO LIMITED at £788.3k based on a Turnover of £3.5m and 0.23x industry multiple (adjusted for size and gross margin).

medimpo limited Estimated Valuation

£0

Pomanda estimates the enterprise value of MEDIMPO LIMITED at £0 based on an EBITDA of £-389.1k and a 2.23x industry multiple (adjusted for size and gross margin).

medimpo limited Estimated Valuation

£1m

Pomanda estimates the enterprise value of MEDIMPO LIMITED at £1m based on Net Assets of £515.1k and 2.03x industry multiple (adjusted for liquidity).

Valuation Calculator
This valuation is estimated based on financial data from November 2022 

Medimpo Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Medimpo Limited Overview

Medimpo Limited is a live company located in croydon, CR0 4RR with a Companies House number of 01761386. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in October 1983, it's largest shareholder is medimpo holdings limited with a 100% stake. Medimpo Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.5m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Medimpo Limited Health Check

Pomanda's financial health check has awarded Medimpo Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

1 Strong

positive_score

4 Regular

positive_score

7 Weak

size

Size

annual sales of £3.5m, make it smaller than the average company (£11.4m)

£3.5m - Medimpo Limited

£11.4m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -8%, show it is growing at a slower rate (5.4%)

-8% - Medimpo Limited

5.4% - Industry AVG

production

Production

with a gross margin of 32.6%, this company has a comparable cost of product (32.6%)

32.6% - Medimpo Limited

32.6% - Industry AVG

profitability

Profitability

an operating margin of -11.4% make it less profitable than the average company (4.8%)

-11.4% - Medimpo Limited

4.8% - Industry AVG

employees

Employees

with 34 employees, this is below the industry average (85)

34 - Medimpo Limited

85 - Industry AVG

paystructure

Pay Structure

on an average salary of £21.6k, the company has an equivalent pay structure (£21.6k)

£21.6k - Medimpo Limited

£21.6k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £102.7k, this is less efficient (£135.2k)

£102.7k - Medimpo Limited

£135.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 37 days, this is later than average (30 days)

37 days - Medimpo Limited

30 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 82 days, this is slower than average (72 days)

82 days - Medimpo Limited

72 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 41 days, this is more than average (30 days)

41 days - Medimpo Limited

30 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 22 weeks, this is average cash available to meet short term requirements (18 weeks)

22 weeks - Medimpo Limited

18 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 64.4%, this is a similar level of debt than the average (64.3%)

64.4% - Medimpo Limited

64.3% - Industry AVG

medimpo limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medimpo limited. Get real-time insights into medimpo limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Medimpo Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for medimpo limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

medimpo limited Ownership

MEDIMPO LIMITED group structure

Medimpo Limited has no subsidiary companies.

Ultimate parent company

1 parent

MEDIMPO LIMITED

01761386

MEDIMPO LIMITED Shareholders

medimpo holdings limited 100%

medimpo limited directors

Medimpo Limited currently has 4 directors. The longest serving directors include Mr Rajendra Patel (May 1992) and Mrs Vandna Patel (May 1992).

officercountryagestartendrole
Mr Rajendra Patel69 years May 1992- Director
Mrs Vandna PatelUnited Kingdom67 years May 1992- Director
Ms Sandhya PatelUnited Kingdom67 years May 1992- Director
Mr Kiran PatelUnited Kingdom65 years Dec 2013- Director

MEDIMPO LIMITED financials

EXPORTms excel logo

Medimpo Limited's latest turnover from November 2022 is estimated at £3.5 million and the company has net assets of £515.1 thousand. According to their latest financial statements, Medimpo Limited has 34 employees and maintains cash reserves of £394.5 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Nov 2022Nov 2021Nov 2020Nov 2019Nov 2018Nov 2017Nov 2016Nov 2015Nov 2014Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Turnover3,491,4363,037,9124,954,0894,443,0714,810,4657,232,5789,925,91510,982,34612,240,20512,154,67011,607,97312,522,49914,002,60610,452,795
Other Income Or Grants00000000000000
Cost Of Sales2,354,1402,071,6473,436,1853,148,9333,358,3214,999,5906,745,6117,669,6049,552,4789,235,7158,955,4058,847,51010,936,9198,000,230
Gross Profit1,137,296966,2651,517,9051,294,1381,452,1442,232,9883,180,3043,312,7422,687,7272,918,9552,652,5683,674,9893,065,6872,452,565
Admin Expenses1,534,372-94,0891,945,2431,225,7561,871,6022,241,5282,501,2073,236,4362,617,5612,785,9832,155,1503,722,5522,290,1931,779,346
Operating Profit-397,0761,060,354-427,33868,382-419,458-8,540679,09776,30670,166132,972497,418-47,563775,494673,219
Interest Payable02,34423,18570,992102,138110,37031,88323,58024,91631,36548,85455,25156,63989,112
Interest Receivable27,0799095178,42310,9287,91000138271229350523310
Pre-Tax Profit-369,9971,058,919-450,0055,812-510,669-111,000647,21452,72645,388101,878448,793-102,464719,378584,417
Tax0-201,1950-1,10400-132,454-48,313-48,460-66,438-150,437-5,926-257,265-211,386
Profit After Tax-369,997857,724-450,0054,708-510,669-111,000514,7604,413-3,07235,440298,356-108,390462,113373,031
Dividends Paid00000090,000144,00082,50092,40092,400129,536241,384206,580
Retained Profit-369,997857,724-450,0054,708-510,669-111,000424,760-139,587-85,572-56,960205,956-237,926220,729166,451
Employee Costs734,850708,030910,277951,9391,109,7761,133,8101,115,8131,169,8881,057,6591,179,148714,243888,922906,546445,038
Number Of Employees3435475160636257565346444041
EBITDA*-389,0741,074,938-395,32986,332-399,10582,531900,579485,789499,423561,508919,137370,3981,196,0141,098,454

* Earnings Before Interest, Tax, Depreciation and Amortisation

Nov 2022Nov 2021Nov 2020Nov 2019Nov 2018Nov 2017Nov 2016Nov 2015Nov 2014Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Tangible Assets31,20539,20794,515200,672223,494905,563996,6341,026,8061,064,1201,075,9861,014,209979,5331,001,099983,300
Intangible Assets0000000191,310572,822969,2171,365,6121,762,0072,158,4022,554,797
Investments & Other00000100100100100100100100100100
Debtors (Due After 1 year)00000000000000
Total Fixed Assets31,20539,20794,515200,672223,494905,663996,7341,218,2161,637,0422,045,3032,379,9212,741,6403,159,6013,538,197
Stock & work in progress267,200279,254387,481549,947539,1641,046,573860,614988,1291,138,873958,244683,000790,000890,000465,400
Trade Debtors356,325277,019714,845478,778474,764884,2951,066,0271,029,728929,589656,659706,3421,156,9161,163,1451,968,632
Group Debtors00000000000000
Misc Debtors397,289178,313188,553347,173237,776395,207202,496238,444180,621245,073121,789243,757203,90274,550
Cash394,4971,410,781407,688627,2481,618,7591,295,3541,868,5681,263,3131,336,8451,716,1351,235,467859,8661,320,5321,416,374
misc current assets00000000000000
total current assets1,415,3112,145,3671,698,5672,003,1462,870,4633,621,4293,997,7053,519,6143,585,9283,576,1112,746,5983,050,5393,577,5793,924,956
total assets1,446,5162,184,5741,793,0822,203,8183,093,9574,527,0924,994,4394,737,8305,222,9705,621,4145,126,5195,792,1796,737,1807,463,153
Bank overdraft00000186,87100134,601262,0680398,404388,193374,855
Bank loan0053,73386,573216,6020181,744165,4630155,694589,256589,256556,205546,166
Trade Creditors 533,947469,807700,965856,148810,8661,620,8751,613,9981,771,6582,076,0562,127,8711,824,1351,862,8891,894,7492,594,018
Group/Directors Accounts0000000177,276307,276241,376342,234272,811333,771186,101
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities391,330823,531974,389158,007361,264284,664458,945286,598308,026236,303259,197180,885384,114252,817
total current liabilities925,2771,293,3381,729,0871,100,7281,388,7322,092,4102,254,6872,400,9952,825,9593,023,3123,014,8223,304,2453,557,0323,953,957
loans0023,129596,7261,203,5691,419,2821,608,0881,555,9721,470,3081,581,8891,055,5861,644,8422,089,7662,645,702
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00000000000000
provisions6,1036,10313,45728,95028,95032,02537,28941,24847,50151,43934,37727,31436,67830,519
total long term liabilities6,1036,10336,586625,6761,232,5191,451,3071,645,3771,597,2201,517,8091,633,3281,089,9631,672,1562,126,4442,676,221
total liabilities931,3801,299,4411,765,6731,726,4042,621,2513,543,7173,900,0643,998,2154,343,7684,656,6404,104,7854,976,4015,683,4766,630,178
net assets515,136885,13327,409477,414472,706983,3751,094,375739,615879,202964,7741,021,734815,7781,053,704832,975
total shareholders funds515,136885,13327,409477,414472,706983,3751,094,375739,615879,202964,7741,021,734815,7781,053,704832,975
Nov 2022Nov 2021Nov 2020Nov 2019Nov 2018Nov 2017Nov 2016Nov 2015Nov 2014Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Operating Activities
Operating Profit-397,0761,060,354-427,33868,382-419,458-8,540679,09776,30670,166132,972497,418-47,563775,494673,219
Depreciation8,00214,58432,00917,95020,35391,07130,17227,97132,86232,14125,32421,56624,12522,545
Amortisation000000191,310381,512396,395396,395396,395396,395396,395402,690
Tax0-201,1950-1,10400-132,454-48,313-48,460-66,438-150,437-5,926-257,265-211,386
Stock-12,054-108,227-162,46610,783-507,409185,959-127,515-150,744180,629275,244-107,000-100,000424,600465,400
Debtors298,282-448,06677,447113,411-566,96210,979351157,962208,47873,601-572,54233,626-676,1352,043,182
Creditors64,140-231,158-155,18345,282-810,0096,877-157,660-304,398-51,815303,736-38,754-31,860-699,2692,594,018
Accruals and Deferred Income-432,201-150,858816,382-203,25776,600-174,281172,347-21,42871,723-22,89478,312-203,229131,297252,817
Deferred Taxes & Provisions0-7,354-15,4930-3,075-5,264-3,959-6,253-3,93817,0627,063-9,3646,15930,519
Cash flow from operations-1,043,3631,040,666335,396-196,941-61,218-287,075906,01798,17977,826444,1291,494,863186,393628,4711,255,840
Investing Activities
capital expenditure040,72474,1484,872661,716008,700-20,996-93,918-60,0000-41,924-48,188
Change in Investments0000-10000000000100
cash flow from investments040,72474,1484,872661,816008,700-20,996-93,918-60,0000-41,924-48,288
Financing Activities
Bank loans0-53,733-32,840-130,029216,602-181,74416,281165,463-155,694-433,562033,05110,039546,166
Group/Directors Accounts000000-177,276-130,00065,900-100,85869,423-60,960147,670186,101
Other Short Term Loans 00000000000000
Long term loans0-23,129-573,597-606,843-215,713-188,80652,11685,664-111,581526,303-589,256-444,924-555,9362,645,702
Hire Purchase and Lease Commitments00000000000000
other long term liabilities00000000000000
share issue000000-70,000000000666,524
interest27,079-1,435-22,668-62,569-91,210-102,460-31,883-23,580-24,778-31,094-48,625-54,901-56,116-88,802
cash flow from financing27,079-78,297-629,105-799,441-90,321-473,010-210,76297,547-226,153-39,211-568,458-527,734-454,3433,955,691
cash and cash equivalents
cash-1,016,2841,003,093-219,560-991,511323,405-573,214605,255-73,532-379,290480,668375,601-460,666-95,8421,416,374
overdraft0000-186,871186,8710-134,601-127,467262,068-398,40410,21113,338374,855
change in cash-1,016,2841,003,093-219,560-991,511510,276-760,085605,25561,069-251,823218,600774,005-470,877-109,1801,041,519

P&L

November 2022

turnover

3.5m

+15%

operating profit

-397.1k

0%

gross margin

32.6%

+2.41%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

November 2022

net assets

515.1k

-0.42%

total assets

1.4m

-0.34%

cash

394.5k

-0.72%

net assets

Total assets minus all liabilities

medimpo limited company details

company number

01761386

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

October 1983

age

41

accounts

Total Exemption Full

ultimate parent company

previous names

N/A

incorporated

UK

address

63 imperial way, croydon, croydon, CR0 4RR

last accounts submitted

November 2022

medimpo limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 22 charges/mortgages relating to medimpo limited. Currently there are 4 open charges and 18 have been satisfied in the past.

charges

medimpo limited Companies House Filings - See Documents

datedescriptionview/download